Interaction ID
ncRI-40641927
Interaction Molecules
hsa-miR-495-3p -- USP28
Interaction Level
RNA-RNA
Interaction Class
binding
Data Source
miRanda with Ago CLIP data
Tags
Organism
Homo sapiens
Tissue or Cell Type
T-REx-293T;HEK293S
Experiment
AGO CLIP
Description
Conserved miRNAs target sites predicted by miRanda overlap with the AGO CLIP dataset
Alias
-
Class
mRNA
Ensembl id
ENSG00000048028
Description
Deubiquitinase involved in DNA damage response checkpoint and MYC proto-oncogene stability. Involved in DNA damage induced apoptosis by specifically deubiquitinating proteins of the DNA damage pathway such as CLSPN. Also involved in G2 DNA damage checkpoint, by deubiquitinating CLSPN, and preventing its degradation by the anaphase promoting complex/cyclosome (APC/C). In contrast, it does not deubiquitinate PLK1. Specifically deubiquitinates MYC in the nucleoplasm, leading to prevent MYC degradation by the proteasome: acts by specifically interacting with isoform 1 of FBXW7 (FBW7alpha) in the nucleoplasm and counteracting ubiquitination of MYC by the SCF(FBW7) complex. In contrast, it does not interact with isoform 4 of FBXW7 (FBW7gamma) in the nucleolus, allowing MYC degradation and explaining the selective MYC degradation in the nucleolus. Deubiquitinates ZNF304, hence preventing ZNF304 degradation by the proteasome and leading to the activated KRAS-mediated promoter hypermethylation and transcriptional silencing of tumor suppressor genes (TSGs) in a subset of colorectal cancers (CRC) cells (PubMed:24623306).
Pubmed ID | 23824327 | Journal | Genes & development |
---|---|---|---|
Title | Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. | ||
Author | Karginov FV, Hannon GJ |
Pubmed ID | 29273203 | Journal | Journal of molecular biology |
---|---|---|---|
Title | Transcriptome-wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. | ||
Author | Li Y, Estep JA, Karginov FV |
Molecule | Disease | Data Source |
---|---|---|
hsa-miR-495-3p | adrenocortical carcinoma | MNDR Database |
hsa-miR-495-3p | AIDS Dementia Complex | MNDR Database |
hsa-miR-495-3p | Alzheimer's disease | MNDR Database |
hsa-miR-495-3p | amyotrophic lateral sclerosis | MNDR Database |
hsa-miR-495-3p | autosomal recessive limb-girdle muscular dystrophy type 2A | MNDR Database |
hsa-miR-495-3p | autosomal recessive limb-girdle muscular dystrophy type 2B | MNDR Database |
hsa-miR-495-3p | bladder urothelial carcinoma | MNDR Database |
hsa-miR-495-3p | bone disease | MNDR Database |
hsa-miR-495-3p | brain disease | MNDR Database |
hsa-miR-495-3p | breast cancer | MNDR Database |
hsa-miR-495-3p | Breast Neoplasms | MNDR Database |
hsa-miR-495-3p | cancer | MNDR Database |
hsa-miR-495-3p | carcinoma | MNDR Database |
hsa-miR-495-3p | Carcinoma, Ductal, Breast | MNDR Database |
hsa-miR-495-3p | Carcinoma, Non-Small-Cell Lung | MNDR Database |
hsa-miR-495-3p | Carcinoma, Renal Cell | MNDR Database |
hsa-miR-495-3p | cervical squamous cell carcinoma | MNDR Database |
hsa-miR-495-3p | cholangiocarcinoma | MNDR Database |
hsa-miR-495-3p | colon cancer | MNDR Database |
hsa-miR-495-3p | colorectal cancer | MNDR Database |
hsa-miR-495-3p | coronary artery disease | MNDR Database |
hsa-miR-495-3p | dermatomyositis | MNDR Database |
hsa-miR-495-3p | diabetes mellitus | MNDR Database |
hsa-miR-495-3p | dilated cardiomyopathy | MNDR Database |
hsa-miR-495-3p | distal muscular dystrophy | MNDR Database |
hsa-miR-495-3p | Duchenne muscular dystrophy | MNDR Database |
hsa-miR-495-3p | endometrial cancer | MNDR Database |
hsa-miR-495-3p | esophageal carcinoma | MNDR Database |
hsa-miR-495-3p | eye disease | MNDR Database |
hsa-miR-495-3p | familiar ovarian carcinoma | MNDR Database |
hsa-miR-495-3p | gastric adenocarcinoma | MNDR Database |
hsa-miR-495-3p | Glioblastoma | MNDR Database |
hsa-miR-495-3p | head and neck squamous cell carcinoma | MNDR Database |
hsa-miR-495-3p | heart disease | MNDR Database |
hsa-miR-495-3p | hepatocellular carcinoma | MNDR Database |
hsa-miR-495-3p | Her2-receptor positive breast cancer | MNDR Database |
hsa-miR-495-3p | Huntington's disease | MNDR Database |
hsa-miR-495-3p | hypersensitivity reaction type II disease | MNDR Database |
hsa-miR-495-3p | intellectual disability | MNDR Database |
hsa-miR-495-3p | leukemia | MNDR Database |
hsa-miR-495-3p | lung cancer | MNDR Database |
hsa-miR-495-3p | lung small cell carcinoma | MNDR Database |
hsa-miR-495-3p | malignant glioma | MNDR Database |
hsa-miR-495-3p | medulloblastoma | MNDR Database |
hsa-miR-495-3p | melanoma | MNDR Database |
hsa-miR-495-3p | Muscular Disorders, Atrophic | MNDR Database |
hsa-miR-495-3p | nasopharynx carcinoma | MNDR Database |
hsa-miR-495-3p | nemaline myopathy | MNDR Database |
hsa-miR-495-3p | nephroblastoma | MNDR Database |
hsa-miR-495-3p | neurodegenerative disease | MNDR Database |
hsa-miR-495-3p | oral squamous cell carcinoma | MNDR Database |
hsa-miR-495-3p | osteosarcoma | MNDR Database |
hsa-miR-495-3p | ovarian carcinoma | MNDR Database |
hsa-miR-495-3p | Ovarian epithelial cancer | MNDR Database |
hsa-miR-495-3p | Ovarian Neoplasms | MNDR Database |
hsa-miR-495-3p | pancreatic adenocarcinoma | MNDR Database |
hsa-miR-495-3p | pancreatic cancer | MNDR Database |
hsa-miR-495-3p | papillary renal cell carcinoma | MNDR Database |
hsa-miR-495-3p | periodontitis | MNDR Database |
hsa-miR-495-3p | progesterone-receptor negative breast cancer | MNDR Database |
hsa-miR-495-3p | progesterone-receptor positive breast cancer | MNDR Database |
hsa-miR-495-3p | prostate adenocarcinoma | MNDR Database |
hsa-miR-495-3p | renal cell carcinoma | MNDR Database |
hsa-miR-495-3p | renal clear cell carcinoma | MNDR Database |
hsa-miR-495-3p | salivary gland cancer | MNDR Database |
hsa-miR-495-3p | squamous cell carcinoma | MNDR Database |
hsa-miR-495-3p | stomach cancer | MNDR Database |
hsa-miR-495-3p | synovial sarcoma | MNDR Database |
hsa-miR-495-3p | temporal lobe epilepsy | MNDR Database |
hsa-miR-495-3p | thyroid cancer | MNDR Database |
hsa-miR-495-3p | thyroid carcinoma | MNDR Database |
hsa-miR-495-3p | urinary bladder cancer | MNDR Database |
hsa-miR-495-3p | uterine corpus endometrial carcinoma | MNDR Database |
hsa-miR-495-3p | vascular disease | MNDR Database |